Predictive factors of toxicity of immune checkpoint inhibitors (ICI) in older patients with lung cancer: The ToxImmune study.

被引：0
|
作者：
Helissey, Carole
Difoum, Francoise
Vanquaethem, Helene
Vuagnat, Perrine
Picchi, Hugo
Le Roy, Audrey
Schernberg, Antoine
机构：
[1] Mil Hosp Begin, Clin Res Unit, St Mande, France
[2] Mil Hosp Begin, St Mande, France
[3] Hop Instruct Armees Begin, St Mande, France
[4] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[5] Mil Hosp Begin, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12048
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Monocytes and neutrophils as a predictive marker of response to immune checkpoint inhibitors (ICI) in metastatic non-small cell lung cancer (mNSCLC).
    Parikh, Kaushal
    Kumar, Arun
    Ahmed, Jibran
    Anwar, Asad
    Puccio, Carmelo
    Chun, Hoo Geun
    Fanucchi, Michael Paul
    Lim, Seah
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung Cancer
    Bianco, Andrea
    Perrotta, Fabio
    Barra, Giusi
    Malapelle, Umberto
    Rocco, Danilo
    De Palma, Raffaele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [23] Immune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer
    Hayashi-Tanner, Yacki
    Polewski, Peter J.
    Gaddam, Mamatha
    Fisher, Nancy R.
    Kovacs, Attila J.
    Marinier, David E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) : 1011 - 1016
  • [24] Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Valette, C. Audigier
    Mazieres, J.
    Lefebvre, C.
    Le Moulec, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A-M. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review
    Slawinski, Grzegorz
    Wrona, Anna
    Dabrowska-Kugacka, Alicja
    Raczak, Grzegorz
    Lewicka, Ewa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 19
  • [26] Predictive factors of grade 3-5 toxicity in older patients with cancer treated with chemotherapy: A prospective multicenter study.
    Feliu Batlle, Jaime
    Basterretxea, Laura
    Dolores Torregrosa, Maria
    Llabres, Elisenda
    Losada Vila, Beatriz
    Jimenez-Munarriz, Beatriz
    Antonio Rebollo, Maite
    Custodio, Ana B.
    Girones, Regina
    Cruz, Patricia
    Munoz Sanchez, Mar
    Pinto, Alvaro
    Soler, Gemma
    Soria Comes, Teresa
    Telleria, Hellis
    Molina-Garrido, Mj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol
    Sannicolo, Sarah
    Levra, Matteo Giaj
    Le Gouellec, Audrey
    Aspord, Caroline
    Boccard, Julien
    Chaperot, Laurence
    Toussaint, Bertrand
    Moro-sibilot, Denis
    Hannani, Dalil
    Toffart, Anne-Claire
    RESPIRATORY MEDICINE AND RESEARCH, 2021, 80
  • [28] Clinical predictive factors of the efficacy of immune checkpoint inhibitors and kinase inhibitors in advanced hepatocellular cancer
    Lu, Yunyun
    Lu, Yi
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (03): : 1142 - 1154
  • [29] Immune checkpoint inhibitors (ICI): From cancer killers to electrolyte disruptors
    Sampat, Parth J.
    Desai, Devashish
    Shahnawaz, Myera
    Ghelani, Ghanshyam H.
    Kallem, Mansi
    Ramovic-Zobic, Merima
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors
    Yao, Liqin
    Jia, Gang
    Lu, Lingeng
    Bao, Ying
    Ma, Wenxue
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
12345